Skip to content
DraconiticResearch
Search Sources API
189,273 studies31 sourcesUpdated 1 h ago
Peer-reviewedLicence not statedLancet Oncology

PD-1 blockade with pembrolizumab in classic or endemic Kaposi's sarcoma: a multicentre, single-arm, phase 2 study

  • Julie Delyon
  • Lucie Biard
  • Marion Renaud
  • Matthieu Resche-Rigon
  • Jérôme Le Goff
  • Stéphane Dalle
  • Valentine Heidelberger
  • Laetitia da Meda
  • Laurie Toullec
  • Guislaine Carcelain
  • Samia Mourah
  • Sophie Caillat-Zucman
3 more authors
  • Vincent Allain
  • Maxime Battistella
  • Céleste Lebbe
Open at sourceDOICite

Related

  1. Pembrolizumab plus lenvatinib in the treatment of unresectable cutaneous angiosarcoma: a study protocol of multicentre, open-label phase II study (NCCH2213, PLAS)
    Dai Ogata, Eiji Nakano, Naoya Yamazaki +10
    BMJ OpenPeer-reviewedCC BY-NC 4.0Full textOncologyCrossref
  2. Immune-checkpoint blockade and candidate predictive biomarkers in HIV-negative Kaposi sarcoma: current evidence and a practical research framework
    Yang Song, Yan Fang, Lin Zeng +1
    Frontiers in ImmunologyPeer-reviewedCC BY 4.0Full textOncologyCrossrefEurope PMCPMC
  3. CT-Based Clinical-Radiomics for Differentiating Talaromyces marneffei Spondylitis From Tuberculous Spondylitis Before Pathogen Confirmation: A Multicentre Diagnostic Study in an Endemic Region.
    Xingqi Zhao, Yilin Teng, Gangyi Wu +6
    MycosesPeer-reviewedCC BY-NC-NDFull textSurgery & anaesthesiaEurope PMC
  4. Clinical Outcomes and Prognostic Factors of Kaposi Sarcoma in a Non-Endemic Region: A Retrospective Cohort Study
    Omar Hamdy, Eman Eid, Rana Reda +8
    CancersPeer-reviewedCC BY 4.0OncologyCrossref
  5. Reconciling motherhood ideology: a classic grounded theory of breastfeeding grief
    T. Aderibigbe
    medRxivPreprintAll rights reservedFull textPsychiatry & mental healthmedRxiv

Cite

BibTeXRIS
BibTeX
@article{delyon2026blockade,
  title = {{PD-1 blockade with pembrolizumab in classic or endemic Kaposi's sarcoma: a multicentre, single-arm, phase 2 study}},
  author = {Julie Delyon and Lucie Biard and Marion Renaud and Matthieu Resche-Rigon and Jérôme Le Goff and Stéphane Dalle and Valentine Heidelberger and Laetitia da Meda and Laurie Toullec and Guislaine Carcelain and Samia Mourah and Sophie Caillat-Zucman and Vincent Allain and Maxime Battistella and Céleste Lebbe},
  journal = {Lancet Oncology},
  year = {2026},
  month = oct,
  doi = {10.1016/s1470-2045(22)00097-3},
  url = {https://hal.science/hal-05783271v1},
}
RIS
TY  - JOUR
TI  - PD-1 blockade with pembrolizumab in classic or endemic Kaposi's sarcoma: a multicentre, single-arm, phase 2 study
AU  - Julie Delyon
AU  - Lucie Biard
AU  - Marion Renaud
AU  - Matthieu Resche-Rigon
AU  - Jérôme Le Goff
AU  - Stéphane Dalle
AU  - Valentine Heidelberger
AU  - Laetitia da Meda
AU  - Laurie Toullec
AU  - Guislaine Carcelain
AU  - Samia Mourah
AU  - Sophie Caillat-Zucman
AU  - Vincent Allain
AU  - Maxime Battistella
AU  - Céleste Lebbe
PY  - 2026
DA  - 2026/10/07
JO  - Lancet Oncology
DO  - 10.1016/s1470-2045(22)00097-3
UR  - https://hal.science/hal-05783271v1
SN  - 1470-2045
SN  - 1474-5488
ER  -